Epidermal Growth Factor Receptor Antagonist [EPC] class drugs

3 results

  • erbitux - cetuximab solution

    (Cetuximab)
    Imclone Llc
    Erbitux treats locally or regionally advanced and recurrent or metastatic squamous cell carcinoma of the head and neck, and K-Ras wild-type, EGFR-expressing metastatic colorectal cancer. Also indicated for BRAF V600E mutation-positive metastatic colorectal cancer with encorafenib after prior therapy.
    Medication Details
    Drug Interactions

  • portrazza - necitumumab solution

    (Necitumumab)
    Eli Lilly And Company
    Portrazza is an EGFR antagonist used with gemcitabine and cisplatin as first-line treatment for metastatic squamous non-small cell lung cancer. Not indicated for non-squamous NSCLC.
    Medication Details
    Drug Interactions

  • vectibix - panitumumab solution

    (Panitumumab)
    Amgen, Inc
    Vectibix (panitumumab) is an EGFR antagonist for adult metastatic colorectal cancer (mCRC). Treats wild-type RAS mCRC with FOLFOX as first-line or as monotherapy after prior chemo. Also treats KRAS G12C-mutated mCRC in combination with sotorasib after prior fluoropyrimidine, oxaliplatin, and irinotecan chemotherapy.
    Medication Details
    Drug Interactions